Skip to Content

Hydralazine Pregnancy and Breastfeeding Warnings

Hydralazine is also known as: Apresoline

Hydralazine Pregnancy Warnings

Use should be avoided during the first two trimesters of pregnancy; use is not recommended during the third trimester unless the benefit outweighs the risk to the fetus. AU TGA pregnancy category: C US FDA pregnancy category: C

Animal studies have revealed evidence of teratogenicity, including cleft palate and malformed facial and cranial bones at higher doses. There are no controlled data in human pregnancy. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Hydralazine Breastfeeding Warnings

During the first week postpartum, 10 lactating women had blood and breast milk samples analyzed 24 hours after receiving a dose between 10 and 40 mg. The average concentration of this drug plus its pharmacologically active acid-labile metabolites in breast milk was 240 nmol/L (about half of the simultaneous concentration in maternal plasma). It was further estimated that the daily dose to a breastfed infant was unlikely to exceed 25 mcg. Serum drug concentrations were measured in 2 infants 2 hours after feeding in this study and were determined to be 557 and 293 nmol/L.

Use is considered acceptable; according to some experts, use only if the benefit outweighs the potential risk. Excreted into human milk: Yes Comments: This drug has been used without apparent harmful effects in the nursing infant.

See references

References for pregnancy information

  1. "Product Information. Apresoline (hydralazine)." Ciba Pharmaceuticals, Summit, NJ.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  4. "Product Information. HydrALAZINE Hydrochloride (hydrALAZINE)." Akorn Inc, Buffalo Grove, IL.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. HydrALAZINE Hydrochloride (hydrALAZINE)." Akorn Inc, Buffalo Grove, IL.
  3. "Product Information. Apresoline (hydralazine)." Ciba Pharmaceuticals, Summit, NJ.
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  5. Cerner Multum, Inc. "Australian Product Information." O 0

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.